ArticleChemical science2025
Interfacial engineering of a nanofibrous Ru/Cr
Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Phase-Engineered Ru-MoC Heterointerfaces for Efficient Alkaline Hydrogen Evolution by Boosting Interfacial Water Dissociation.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Interface charge engineering of ternary RuCoMo oxide nanofibers toward high-current-density water electrolysis.Chemical science · 2026Article
- Single-atom catalysts meet electrospinning: a blissful marriage for energy catalysis.Chemical science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interfacial engineering of a heterostructured electrocatalyst is an efficient way to boost hydrogen production, yet it still remains a challenging task to achieve superior performance at ampere-grade current density. Herein, a nanofibrous Ru/Cr
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.